Erratum to “Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy”

Table 5

The urine albumin/creatine ratio (mg/mg) in different groups (x ± s).

Time after adriamycin	Urine albumin/creatine (mg/mg)
	C	M	M + Z	M + S	M + Z + S
Week 0			1.69 ± 0.75
Week 1	1.63 ± 0.49	2.13 ± 0.25^★	1.82 ± 0.25	1.69 ± 0.38^▲	1.64 ± 0.23^▲
Week 2	1.67 ± 0.40	2.19 ± 0.33^★	2.02 ± 0.23	1.87 ± 0.12^▲	1.82 ± 0.06^▲
Week 3	1.63 ± 0.32	2.30 ± 0.28^★	2.02 ± 0.09^▲	1.97 ± 0.04^▲	1.86 ± 0.21^#
Week 4	1.64 ± 0.67	2.54 ± 0.39^★	2.06 ± 0.21^▲	2.04 ± 0.07^▲	1.93 ± 0.09^#

Control group (C), adriamycin group (M), adriamycin + nephropathy prescription I group (M + Z), adriamycin + prednisone acetate group (M + S), and adriamycin + nephropathy prescription I + prednisone acetate group (M + Z + S). ^★M vs. control group at the same time point (), ^▲M + S vs. M group at the same time point (), and ^#M + Z + S vs. M group at the same time point ().